ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saita, N.
Right arrow Articles by Hirashima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saita, N.
Right arrow Articles by Hirashima, M.
Eur Respir J 2001; 17:190-194
Copyright ©ERS Journals Ltd 2001


Apoptotic response of eosinophils in chronic eosinophilic pneumonia

N. Saita1, T. Yamanaka1, H. Kohrogi1, M. Ando1 and M. Hirashima2

1 First Dept of Internal Medicine, School of Medicine, Kumamoto University, Kumamoto, Japan and 2 Dept of Immunology and Immunopathology, Kagawa Medical School, Kagawa, Japan

CORRESPONDENCE: N. Saita, First Dept of Internal Medicine, School of Medicine, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-0811, Japan. Fax: 011 81963710582

Keywords: chronic eosinophilic pneumonia, eosinophil apoptosis, interleukin-5

Received: November 3, 1999
Accepted September 5, 2000

To clarify the pathogenesis of chronic eosinophilic pneumonia (CEP), the apoptosis of eosinophils from bronchoalveolar lavage (BAL-Eos) was compared with that of eosinophils from peripheral blood (PB-Eos) in six cases of CEP.

The survival rate of eosinophils and the percentage of apoptotic cells of both types of eosinophils were examined, and the effects of interleukin 5 (IL-5) were evaluated. The role of Fas expression in apoptosis of these eosinophils was also studied.

The survival rate of BAL-Eos on the third day of culture was significantly higher than that of PB-Eos (p<0.01). This was associated with a lower proportion of apoptotic cells in BAL-Eos than in PB-Eos; the percentages of apoptotic cells in PB-Eos and BAL-Eos after 24 h of incubation were 21.7±3.4% and 10.6±1.7% respectively. IL-5 suppressed apoptosis and increased the survival rate of both PB-Eos and BAL-Eos. It was found that the apoptotic character of BAL-Eos differed from that of PB-Eos in at least three ways. Firstly, the positive rate of Fas expression on PB-Eos was increased after 24 h of incubation, whereas that on BAL-Eos did not change. Secondly, the expression of Fas on PB-Eos was suppressed by IL-5 (18.5±4.2%–8.3±3.2%, p<0.05), whereas IL-5 failed to suppress Fas expression on BAL-Eos (3.3±1.6%–3.6±1.0%). Lastly, binding of antibody to Fas antigen induced apoptosis of PB-Eos, but not of BAL-Eos.

These data suggested that Fas seemed to be involved in the apoptosis of PB-Eos, whereas BAL-Eos were Fas-resistant in chronic eosinophilic pneumonia. In conclusion, apoptosis of eosinophils might be suppressed by proinflammatory cytokines such as IL-5 leading to their accumulation in the lung. Chronic stimulation of eosinophils in the alveolar space with IL-5 may play a crucial role chronic eosinophilic disorders.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Machida, H. Inoue, K. Matsumoto, M. Tsuda, S. Fukuyama, H. Koto, H. Aizawa, Y. Kureishi, N. Hara, and Y. Nakanishi
Activation of PI3K-Akt pathway mediates antiapoptotic effects of {beta}-adrenergic agonist in airway eosinophils
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L860 - L867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Langdon, C. Kerr, L. Tong, and C. D. Richards
Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice
J. Immunol., January 1, 2003; 170(1): 548 - 555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.